首页> 生物试剂> 其他生物试剂> 其他> TRA-UAS-BLA HEK 293T CELLS 1 KIT,K1684,Invitrogen

TRA-UAS-BLA HEK 293T CELLS 1 KIT,K1684,Invitrogen

市场价: 询价 / 套
在线询价
优    惠: 请询价
订货号 2UL1807
品牌型号 Invitrogen K1684
货期 询货期
最小订货量 1套
联系我们
  • 400-920-3909
  • 商品介绍
  • 规格参数
  • 包装参数
产品介绍 Product Description
规格
Alternate Agonists: 9-cis-retinoic acid, TTNPB, CD437, AM 580
Antagonists: AGN 193109
Assay Entry: Cell-based beta lactamase reporter gene
Cell State: Dividing Cells
Druggable Target: Nuclear Receptors
Primary Agonist: All-trans-retinoic Acid
Product Line: GeneBLAzer®
Reporter Gene: BLA (Beta-Lactamase)
System Type: GeneBLAzer™
Target Entry: THRA, TR alpha, NR1A1
Detection Method: Fluorescent
储存
Shipping: Dry IceStorage: -80°C/Liquid NitrogenContains: TR alpha-UAS-bla HEK 293T cells (K1260)
描述

TR alpha-UAS-bla HEK 293T cells contain the ligand-binding domain (LBD) of the human Thyroid hormone receptor alpha(TR alpha) fused to the DNA-binding domain of GAL4 stably integrated in the GeneBLAzer®UAS-bla HEK 293T cell line. GeneBLAzer®UAS-bla HEK 293T cells stably express a beta-lactamase reporter gene under the transcriptional control of an upstream activator sequence (UAS). When an agonist binds to the LBD of the GAL4 (DBD)-TR alpha (LBD) fusion protein, the protein binds to the UAS, resulting in expression of beta-lactamase. TR alpha-UASbla HEK 293T 293 cells are functionally validated for Z' and EC50 concentrations of T3 Thryoid hormone. In addition, TR alpha-UAS-bla HEK 293T 293 cells have been tested for assay performance under variable conditions, including DMSO concentration, cell number, stimulation time, and substrate loading time (data available upon request). Additional testing data using alternate stimuli are also available.

长度(mm)
宽度(mm)
高度(mm)
重量(kg)
猜你喜欢

在线
客服

在线客服服务时间:09:00-18:00

客服
热线

400-920-3909
客服服务热线 周一至周五(09:00-18:00)

微信
咨询

微信小程序 7X24小时在线咨询